Stock listing
Hamburg:430 Terns Pharmaceuticals, Inc. Aktie
German listing (Hamburg) of Terns Pharmaceuticals, Inc. · home listing NASDAQ:TERN
Follow Terns Pharmaceuticals, Inc. into a list and get an email when it puts out news.

- Ticker
- Hamburg:430
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Hamburg
- Currency
- EUR
What changed lately
Latest news release · Sep 10, 2026
TERN Awarded $11.26 Million U.S. Army Contract to Deploy Next Generation Positioning, Navigation, and Vehicle Readiness Systems
Latest news
Terns Pharmaceuticals, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 10 in the last 12 months · 120 in all · newest Sep 10, 2026 · oldest 2021
- Decks
- 1 deck · latest Jun 14, 2021
Where Terns Pharmaceuticals, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:TERN · Home listing | NASDAQ | United States | USD |
| gettex:430 | gettex | Germany | EUR |
| LS Exchange:A2QNWR | LS Exchange | Germany | EUR |
| Tradegate:430 | Tradegate | Germany | EUR |
| Lang & Schwarz:A2QNWR | Lang & Schwarz | Germany | EUR |
| BOATS:TERN | BOATS | United States | USD |
| Stuttgart:430 | Stuttgart | Germany | EUR |
| Frankfurt:430 | Frankfurt | Germany | EUR |
| Dusseldorf:430 | Dusseldorf | Germany | EUR |
| Hamburg:430 · This page | Hamburg | Germany | EUR |
| Munich:430 | Munich | Germany | EUR |
Team and board
Officers
| Officer | Role |
|---|---|
| Andrew Gengos | Chief Financial Officer |
Board
| Director | Role |
|---|---|
| Heather Turner | Director |
| Robert Azelby | Director |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Technical Presentation (June 2021) | Technical | 31 slides | Jun 14, 2021 |
Financings
| Raise | Date |
|---|---|
| Public offering of common stock Closed: US$747.5M raised · US$40 a share · Jefferies +5 Dealers: Jefferies (co-lead), TD Cowen (co-lead), Leerink Partners (co-lead), Mizuho, Citizens Capital Markets, Oppenheimer & Co. Use of proceeds: Research, clinical trials, development and manufacturing of product candidates including TERN-701, pre-launch activities, working capital and general purposes | Dec 11, 2025 |
Open Financings · Read by 6ix AI from the company's releases
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Robert Azelby Other companies: Tango Therapeutics, Inc. (Chairman; Former President and CEO, Eliem Therapeutics, Inc. · Since at least Jun 19, 2026); Autolus Therapeutics plc (Director · Since at least Mar 18, 2026); Cardinal Health, Inc. (Director · Since at least Mar 1, 2024); ADC Therapeutics SA (Director · Since at least Jan 2, 2024); Aduro Biotech Inc (Director · Apr 10, 2023 – Aug 11, 2023 · Past); Climb Bio, Inc. (President & CEO, Director · Aug 9, 2021 – Oct 31, 2022 · Past); Immunomedics Inc (Director · Feb 26, 2020 – Oct 23, 2020 · Past); Clovis Oncology Inc (Director · Oct 11, 2018 – Jun 10, 2021 · Past); Alder BioPharmaceuticals Inc (President and CEO, Director · Jun 13, 2018 – Oct 22, 2019 · Past); Cascadian Therapeutics Inc (Director · Mar 31, 2017 – Mar 9, 2018 · Past); Juno Therapeutics Inc (EVP & Chief Commercial Officer · Nov 1, 2015 – Mar 5, 2018 · Past) | Director · Since at least Feb 20, 2025 |
| Andrew Gengos Other companies: Immuneering Corporation (Chief Financial Officer and Treasurer · Since at least Jul 16, 2026); Turn Therapeutics Inc. (Director · Since at least Oct 7, 2025); LeonaBio, Inc. (CFO and Chief Business Officer · May 18, 2023 – Sep 3, 2024 · Past); Cyteir Therapeutics Inc (Chief Business Officer · Jun 17, 2021 – Feb 22, 2022 · Past); Synlogic Inc (Chief Operating Officer · Oct 9, 2017 – Mar 14, 2018 · Past) | Chief Financial Officer · Since at least Feb 24, 2025 |
| Heather Turner Other companies: Avalyn Pharma Inc. (Director · Since at least Apr 29, 2026); LB Pharmaceuticals Inc (Chief Executive Officer, Director · Since at least Sep 10, 2025); Lyell Immunopharma, Inc. (Chief General Counsel · Jun 16, 2021 – Mar 16, 2022 · Past); Sangamo Therapeutics, Inc. (EVP, General Counsel & Sec. · Feb 12, 2018 – Feb 25, 2019 · Past); Atara Biotherapeutics, Inc. (Former EVP, GC & Sec. · Feb 6, 2018 – Feb 9, 2018 · Past) | Director · Since at least Nov 18, 2024 |
| Jeffrey Kindler Other companies: Praxis Precision Medicines, Inc. (Director · Since at least Jan 8, 2026); Precigen, Inc. (Director · Since at least Dec 28, 2023); Perrigo Company plc (Director · May 14, 2024 – May 14, 2025 · Past) | Director · Since at least Jun 10, 2024 |
| Jill Quigley Other companies: Filana Therapeutics, Inc. (Director · Since at least Nov 11, 2026); Chemomab Therapeutics Ltd. (Board Director · Since at least Jun 16, 2022); Passage Bio, Inc. (Chief Operating Officer · Feb 27, 2020 – Dec 8, 2021 · Past) | Director · Since at least Feb 4, 2021 |
| Hongbo Lu Other companies: Zenas BioPharma, Inc. (Director · Since at least Sep 12, 2024); Arrowhead Pharmaceuticals, Inc. (Director · Since at least Mar 15, 2024) | Director · Since at least Jun 10, 2024 |
| Radhika Tripuraneni M.D. Other companies: Viridian Therapeutics, Inc. (Chief Medical Officer · Since at least Feb 27, 2025); Prothena Corporation plc (Chief Development Officer · Feb 25, 2020 – Feb 23, 2022 · Past) | Director · Since at least Jul 26, 2022 |
| Seokho Bryan Yoon Other companies: LogicBio Therapeutics Inc (Chief Admin Officer & GC · Nov 11, 2019 – Apr 15, 2020 · Past); Nightstar Therapeutics PLC (General Counsel and Secretary · Jan 1, 2019 – Jun 6, 2019 · Past) | COO and General Counsel · Feb 4, 2021 – May 31, 2024 · Past |
| Amy Burroughs Other companies: Tenaya Therapeutics, Inc. (Board Member · Since at least Oct 18, 2024) | Chief Executive Officer, Director · Since at least Feb 7, 2024 |
| David Eric Strauss Other companies: Bellicum Pharmaceuticals Inc (Sr Director, Corp Controller · Jan 8, 2020 – Dec 15, 2020 · Past) | Principal Accounting Officer · Feb 1, 2025 – Feb 1, 2025 · Past |
All 17 people
| Person | Seat |
|---|---|
| Emil Kuriakose Other companies: Calithera Biosciences, Inc. (CHIEF MEDICAL OFFICER · Nov 5, 2021 – Jan 23, 2023 · Past) | Chief Medical Officer · Since at least Mar 10, 2024 |
| Mark J Vignola Other companies: Applied Therapeutics Inc (Chief Financial Officer · May 13, 2019 – May 13, 2019 · Past) | Chief Financial Officer · Feb 4, 2021 – Jan 2, 2025 · Past |
| Melita Sun Jung Other companies: Structure Therapeutics, Inc. (Chief Business Officer · Feb 2, 2023 – Feb 7, 2023 · Past) | Chief Business Officer · Apr 22, 2024 – Jan 30, 2025 · Past |
| Ann Elizabeth Taylor | Director · Sep 28, 2021 – Jul 1, 2024 · Past |
| David A Fellows | Director · Since at least Jun 11, 2025 |
| Erin Quirk | President, Head of R&D · Feb 4, 2021 – Jan 23, 2024 · Past |
| Weidong Zhong | Chief Scientific Officer, Director · Feb 4, 2021 – Feb 4, 2021 · Past |
Log in to ask 6ix AI your own questions about Terns Pharmaceuticals, Inc.